Objective: To survey the basic educational courses on Regulatory Science(RS)for drug development required by the model core curriculum for pharmaceutical education. Methods: We collected the online syllabi of pharmaceutical schools for the year of 2017 in Japan and identified the course related to drug development. Survey items included basic course information(e. g. targeted student grades, the number of credits, course names, course classification, and lecturer)as well as information on the

more »

... cturer; whether the lecturer was a member of the RS committee at the council on pharmaceutical education. Results and Discussions: We found that all pharmaceutical schools offered drug development courses and 78.2% of them required it as a compulsory subject. Therefore, it is indicated that drug development education has been penetrated broadly in Japanese pharmaceutical schools and its importance has been well recognized. However, differences in the number of credits and courses among schools suggested that ranges and contents of the courses may vary. Furthermore, provided that private universities had significantly better results compared to public universities, private universities may offer a detailed educational course with more contents on drug development. Conclusion: RS has established its position in the Japanese pharmaceutical education. However, implementation of standardized curriculum to suppress variations in drug development education should be considered. Likewise, a further enhancement of basic RS education; notably in public universities, is needed. 抄 録 1 慶應義塾大学薬学部医薬品開発規制科学講座 〒105-8512 東京都港区芝公園1-5-30 2 慶應義塾大学病院臨床研究促進センター * 連絡先著者 (受付:2019.1.29 受理:2019.4.5.